Overview

Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
0
Participant gender:
All
Summary
In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
American University of Beirut Medical Center
Treatments:
Anesthetics
Dexmedetomidine
Criteria
Inclusion Criteria:

- 18-80 year-old

- ASA class I, II, and III

- patients undergoing elective surgery under general anesthesia with an estimated time
of 1-3 h

Exclusion Criteria:

- duration of surgery less than 1h or more than 3 h

- allergy to dexmedetomidine

- vasoactive antidepressant or analgesics

- obesity (BMI>30)

- fever

- pregnancy